Gun Shot Wound takes a hard look at routine gun violence in America through the eyes of its trauma surgeons. The film examines the crisis through a public health lens and highlights hospital-based violence intervention programs designed to combat the epidemic.
Every day in the United States, an average of 318 people are shot—about 116,000 victims each year. Most aren’t involved in mass shootings; instead they’re caught in the web of routine, almost invisible, gun violence. More than 35,000 of these victims will die from their wounds.
Dr. Amy Goldberg leads the team that treats more than 500 gunshot victims each year. In 2019, someone was shot every 6 1⁄2 hours in Phildelphia, where she works. We follow Dr. Goldberg on a busy Friday evening in the trauma centre. In the space of 12 hours, she’ll treat three gunshot victims and perform emergency life-saving surgery on one of them. And since 80% of gunshot victims survive in Philadelphia, Gun Shot Wound gives an authentic look at the daunting process of rehab and often permanent disability. Meanwhile, Dr Joseph Sakran shares his day-to-day experience treating gunshot victims in Baltimore and introduces viewers to Brandon Fisher. Brandon arrived at the trauma bay nearly dead with 13 bullet wounds and injuries in almost every cavity in his body. It took a multi-disciplinary team of surgeons and more than 15 surgeries for Brandon to recover.
Gun Shot Wound shows what really happens when someone gets shot and highlights how physicians and hospitals are not just treating patients, but going above and beyond to prevent gun violence.
Can magic mushrooms cure depression?
Over two years we follow the first ever medical trial of psilocybin (the psychoactive ingredient in magic mushrooms) being used to treat a group of volunteers suffering from clinical depression.
This remarkable film follows three volunteers and their families, and the ambitious staff running the trial, who are hoping this controversial treatment will have the power to transform millions of lives.
With deeply moving footage of the ‘trips’ the patients go on, as well as interviews providing scientific and political context, this intimate film is an absorbing portrait of the human cost of depression, and the inspirational people contributing to groundbreaking psychedelic research.
“Monty Wates’s documentary shows the work of Dr Robin Carhart-Harris at Imperial College London: after years of bureaucratic wrangling, he got permission to conduct research into the possibility that psilosybin – the psychoactive ingredient of magic mushrooms – could be used to treat depression. Is society’s taboo disapproval needlessly holding back our understanding of this issue?
We see three long-time sufferers of depression, sensitively interviewed about their lives… They are given a low, introductory dose of shroom-essence at the first session, and at the second the amount is stepped up. The results are startling”
Peter Bradshaw, The Guardian
Ayhuasca: Expansion of Consciousness, tells the story of Ayahuasca, from its emergence in the Amazonian Forest, to its popularity with the Santo Daime religion, and on to its arrival in urban centres.
Combining scientific, religious and anthropological perspectives on the use of Ayahuasca in modern society, and in parallel with the director Fausto Noro’s own healing process, Ayhuasca: Expansion of Consciousness provides for the first time, a holistic, yet balanced view of this controversial subject.
Stem Cell research and therapy have been growing at a rapid rate over the past fifteen years. Scientific advances coupled with consumer demand have proven that stem cell therapy is the wave of the future, and is poised to change the face of medicine.
The only hurdles have been religious and regulatory roadblocks slowing down the approval process for fetal stem cell therapy, arguably the most contested and controversial form of stem cell therapy to date, due to them being harvested from abortions.
The God Cells takes the audience on a journey with those who seek the life changing fetal stem cell therapy abroad, while avoiding the seemingly insurmountable roadblocks at home.
“The demand is real, patients with current unmet medical needs are desperate and require this therapy, but the current regulatory and industry hurdles are making it near impossible for us to do our job and get these important stem cell therapies to those people in need. Because of this, many scientific organizations are taking their technology abroad to appease patient demand, because they feel the current regulatory hurdles are insurmountable.”
Randal Mills, PhD, President and CEO for California Institute For Regenerative Medicine